In addition, it has been demonstrated that high levels of hepatic miR-34a by targeting ubiquitin-specific peptidase 10 (USP10) reduced its expression, promoting the development of NAFLD [69]. Here, USP10 is linked to metabolic dysfunction-associated steatotic liver disease.